Identification of a Novel Tumor Angiogenesis Inhibitor Targeting SHH/Gli1 Signaling Pathway in Non-Small Cell Lung Cancer

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-020-2425-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Angiogenesis in Advanced Non-Small-Cell Lung Cancer: Are Biomarkers Needed?

Current Respiratory Care Reports
2013English

P53 and Angiogenesis in Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

A Novel PI3K Inhibitor iMDK Suppresses Non-Small Cell Lung Cancer Cooperatively With a MEK Inhibitor

Experimental Cell Research
Cell Biology
2015English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

A Novel Imidazopyridine PI3K Inhibitor With Anticancer Activity in Non-Small Cell Lung Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2013English

Interleukin-17 Promotes Angiogenesis by Stimulating VEGF Production of Cancer Cells via the STAT3/GIV Signaling Pathway in Non-Small-Cell Lung Cancer

Scientific Reports
Multidisciplinary
2015English

miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2019English

A Novel Small Inhibitor, LLL12, Targets STAT3 in Non‑small Cell Lung Cancer In�vitro and In�vivo

Oncology Letters
Cancer ResearchOncology
2018English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy